Business Wire

Masimo SET ® Pulse Oximetry: Superior Performance, Worldwide Presence, Immeasurable Impact

Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than 100 ...
Business Wire

Retrospective Study Finds That Masimo SET ® Pulse Oximetry Has No Difference in Accuracy or Bias Between Black People and White People

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of an abstract presented last Saturday at the Society for Technology in Anesthesia 2022 Annual Meeting, which ...
Nasdaq

Masimo Launches Dual SET® Pulse Oximetry

NEUCHATEL, Switzerland--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) today announced Dual SET® Pulse Oximetry for Root®, a highly versatile patient monitoring and connectivity hub. The first application of ...
BioWorld

Masimo Set provides clinically accurate pulse oximetry results regardless of skin color

Masimo Corp.’s pulse oximetry technology avoids the dangerous under-recognition of low oxygen levels in people of color that plagues many pulse oximeters on the market, a peer-reviewed study in the ...
Nasdaq

Masimo Announces the First FDA-cleared "Over-the-Counter" Fingertip Pulse Oximeter

Joe Kiani, Founder and CEO of Masimo, said, “Until now, consumers and even healthcare providers had no way of knowing what pulse oximeter they could trust to use at home. On the internet and even in ...
MD&M East

GE Healthcare & Masimo Collab to Integrate Pulse Oximetry into Portrait Mobile

GE Healthcare and Masimo have announced a joint agreement to integrate Masimo’s Signal Extraction Technology (SET) pulse oximetry into GE’s Portrait Mobile wireless and wearable patient monitoring ...
FierceBiotech

Masimo paints pulse oximetry tech onto GE HealthCare's Portrait patient monitoring system

More than a decade into their partnership, Masimo and GE HealthCare are still finding new ways to combine their respective patient monitoring technologies. In the latest expansion of their ...
Seeking Alpha

In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones

The INSPIRE Trial Prospectively Assesses Pulse Oximeter Accuracy Using a Unique Real-world Study Design and in the Feasibility Study Showed No Clinically Significant Bias Between Patients with Light ...
FierceBiotech

Masimo reels in FDA nod for pulse oximetry smartwatch amid Apple Watch patent spats

About a year after beginning its full market launch, Masimo’s W1 smartwatch can now be used as a medical device in the U.S. The wearable device has earned FDA clearance for its medical applications, ...
Orange County Business Journal

Masimo Awaits Ban on Apple Watches

FDA gives nation’s only approval for pulse oximetry monitoring to Masimo’s watch Masimo Corp. (Nasdaq: MASI) is about to get a special gift, the day after Christmas. That’s when the U.S. government is ...
Morningstar

In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones

In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones The INSPIRE Trial Prospectively Assesses Pulse ...